Coronary Artery Disease, Hyperoxia, Hypoxia, Myocardial Reperfusion Injury
Conditions
Keywords
myocardial protection, preconditioning, hypoxia, hyperoxia, ischemia-reperfusion injury, cardiopulmonary bypass, oxygen transport
Brief summary
Coronary artery bypass grafting (CABG) with cardiopulmonary bypass is a common surgical therapy for patients suffering from coronary artery diseases. The heart is subjected to a long period of ischemia due to the occlusion of the aorta. The heavy burden of myocardial ischemia-reperfusion injury (IRI) thus induces cardiomyocyte death, which can paradoxically reduce the beneficial effect of CABG. Preconditioning by moderate hypoxia or hyperoxia serves as an effective drug-free method to increase the organism's resistance to negative effects, including IRI.
Detailed description
It has been firmly established that the diminished oxygen delivery to the tissues in response to hypoxia is countered by a combination of the increased regional blood flow and the enhanced functional capillary density in the microcirculation. In experimental studies, exposure to hyperoxia for a limited time before ischemia induces a low-grade systemic oxidative stress evokes a preconditioning-like effect on the myocardium and reduces the infarction area by 20%, and the number of arrhythmias after ischemia-reperfusion. One hundred twenty patients were randomly assigned into two equal groups: hypoxic-hyperoxic preconditioning before the surgery (HHP group) and the control group (without preconditioning). Safety control of the preconditioning procedure included ECG monitoring, invasive blood pressure, cardiac output, pulse oximetry, capnography, cerebral oximetry, measurement of anaerobic threshold; acid-base status and metabolic state of arterial and venous blood were assessed once every 10 min during the preconditioning procedure; oxygen balance parameters were calculated. Seventy-two hours before the surgery, an anaerobic threshold was determined to establish a safe oxygen concentration in the respiratory gas mixture during the hypoxic preconditioning phase from 10 to 14%, followed by 75-80% oxygen concentration during the hyperoxic phase. The hypoxic-hyperoxic preconditioning with individual parameters selection based on the anaerobic threshold in patients with coronary artery diseases before the main stage of cardiac surgery with a cardiopulmonary bypass should reduce the duration of mechanical ventilation, catecholamine support, and frequency of perioperative complications.
Interventions
Patients were intubated and mechanically ventilated with the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively) under the inhalation anesthesia. HHP was carried out as follows: breathing with a hypoxic gas mixture for 10 min with the development of hypoxemia, then breathing with a hyperoxic gas mixture for 30 minutes, then a period of breathing with atmospheric air (normoxia and normocapnia) until the cardio-pulmonary bypass is connected.
Patients were intubated and mechanically ventilated with the target values of PaO2 and PaCO2 (80 - 120 mm Hg and 35 - 45 mm Hg, respectively) under the inhalation anesthesia until the cardio-pulmonary bypass is connected.
Sponsors
Study design
Eligibility
Inclusion criteria
* the need for coronary artery bypass grafting (CABG)
Exclusion criteria
* age over 75 years * emergency surgery * diabetes mellitus * exacerbation of a chronic disease 1 week before surgery * any oncological disease at the time of the examination
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants with complications | 60 days | Any type of complications in postoperative period |
| Mechanical ventilation | 60 days | Mechanical ventilation time |
| Rate of spontaneous sinus rhythm recovery | 14 days | Spontaneous sinus rhythm recovery after surgery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Catecholamine support | 60 days | Catecholamine support time |
| Troponin T | 12 hours | Troponin T concentration |
| Endothelin-1 | 1 day before surgery | Endothelin-1 concentrations |
| Endothelin-1 dynamics 1 | at the end of surgery | Endothelin-1 concentrations |
| Endothelin-1 dynamics 2 | 24 hours after surgery | Endothelin-1 concentrations |
| NOx total | 1 day before surgery | NOx total concentrations |
| NOx total dynamics 1 | at the end of surgery | NOx total concentrations |
| NOx total dynamics 2 | 24 hours after surgery | NOx total concentrations |
| Asymmetric dimethylarginine (ADMA) | 1 day before surgery | ADMA concentrations |
| ADMA dymanics 1 | at the end of surgery | ADMA concentrations |
| ADMA dymanics 2 | 24 hours after surgery | ADMA concentrations |
Contacts
Federal Research Clinical Center FMBA Russia